Product containing precisely thioridazine 30 mg/1 mL conventional release oral solution (clinical drug)
RxNorm 313358
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 313358 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Product containing precisely thioridazine 30 mg/1 mL conventional release oral solution (clinical drug).
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
Semantic Clinical Drug (SCD):
Thioridazine 30 mg/ML Oral Solution
(Atom ID: 12340035)
Full form of descriptor (FN):
Product containing precisely thioridazine 30 mg/1 mL conventional release oral solution (clinical drug)
(Atom ID: 11440821)
Designated preferred name (PT):
Thioridazine 30 mg/mL oral solution
(Atom ID: 11441496)
Patient Education
Thioridazine
Thioridazine is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions) in people who have already been treated with at least 2 other medications and have not been helped or who have experienced severe side effects. Thioridazine is in a group of medications called conventional antipsychotics. It works by decreasing abnormal excitement in the brain.
[Learn More]
* Please review the disclaimer below.
